Suviray Injection
Prescription Required
Product introduction
Suviray Injection is a calcitonin gene-related peptide receptor antagonist. It is used in the preventive treatment of migraine in adults. It works by blocking the receptors for the protein CGRP, thought to play a major role in starting migraines.
Suviray Injection is given as an injection in the abdomen, thigh, or upper arm subcutaneously. Before administering the injection, allow the medicine to be at room temperature for at least 30 minutes protected from direct sunlight. Do not warm by using a heat source such as hot water or a microwave. Do not inject the medicine into areas where the skin is tender, bruised, or hard.
The most common side effects of this medicine are injection site reactions (such as pain, swelling, and redness) and constipation. It may also cause itching and muscle spasms in some people. If you experience such side effects that do not heal on their own or get worse, inform your doctor. They may be able to help you reduce or treat the side effects.
Do not use Suviray Injection if you are allergic to erenumab or any ingredients of the medicine. Before using the doctor about all your medical conditions. To make sure it is safe for you, let your doctor also know if you are pregnant, planning to become pregnant, or breastfeeding.
Suviray Injection is given as an injection in the abdomen, thigh, or upper arm subcutaneously. Before administering the injection, allow the medicine to be at room temperature for at least 30 minutes protected from direct sunlight. Do not warm by using a heat source such as hot water or a microwave. Do not inject the medicine into areas where the skin is tender, bruised, or hard.
The most common side effects of this medicine are injection site reactions (such as pain, swelling, and redness) and constipation. It may also cause itching and muscle spasms in some people. If you experience such side effects that do not heal on their own or get worse, inform your doctor. They may be able to help you reduce or treat the side effects.
Do not use Suviray Injection if you are allergic to erenumab or any ingredients of the medicine. Before using the doctor about all your medical conditions. To make sure it is safe for you, let your doctor also know if you are pregnant, planning to become pregnant, or breastfeeding.
Uses of Suviray Solution for Injection
Benefits of Suviray Solution for Injection
In Prevention of Migraine
Suviray Injection blocks the action of a certain natural substance in the body that causes migraine headaches. This prevents migraines. By preventing and reducing the frequency of migraine headaches, it can help you carry out your daily activities and have a better quality of life.
Side effects of Suviray Solution for Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Suviray
- Injection site reactions (pain, swelling, redness)
- Constipation
- Itching
How to use Suviray Solution for Injection
Your doctor or nurse will guide you how to use this medicine.
How Suviray Solution for Injection works
Suviray Injection is a human monoclonal antibody. It works by binding to the calcitonin gene-related peptide (CGRP) receptor and antagonizes CGRP receptor function.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Suviray Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Suviray Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Suviray Injection during breastfeeding is not available. Please consult your doctor.
Driving
SAFE
Suviray Injection does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Suviray Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Suviray Injection may not be needed in these patients. Please consult your doctor.
Liver
SAFE IF PRESCRIBED
Suviray Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Suviray Injection may not be needed in these patients. Please consult your doctor.
What if you forget to take Suviray Solution for Injection?
If you miss a dose of Suviray Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Consult your doctor immediately if you notice any sign of severe allergic reactions like rash or breathing difficulties.
- Monitor your blood pressure at home at regular intervals and inform your doctor if you experience a rise in your blood pressure.
- You can apply an ice pack on the injection site if you experience pain and redness.
- You may experience severe constipation after taking Suviray Injection. Inform your doctor who may prescribe medicines accordingly or discontinue this medicine in case of constipation with serious complications.
- Do not give Suviray Injection to anyone else, even if they have the same symptoms that you have since it can harm them.
- Some tips that may help avoid a migraine attack:a) Have your meals at the same time every day.b) Avoid bright lights and extreme temperatures.c) Avoid loud music and noisy places.d) Avoid chocolates, cheese, processed food, alcohol, and smoking.f) Get sufficient sleep and avoid stress.
Fact Box
Chemical Class
Peptides
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Monoclonal antibodies
Interaction with drugs
Taking Suviray with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Concurrent use may increase the risk of constipation.
If concurrent use is essential, watch out for symptoms such as constipation, muscle cramps, injection site reactions, dizzine
Concurrent use may increase the risk of constipation.
If concurrent use is essential, watch out for symptoms such as constipation, muscle cramps, injection site reactions, dizzine
Concurrent use may increase the risk of constipation.
If concurrent use is essential, watch out for symptoms such as constipation, muscle cramps, injection site reactions, dizzine
Concurrent use may increase the risk of constipation.
If concurrent use is essential, watch out for symptoms such as constipation, muscle cramps, injection site reactions, dizzine
Concurrent use may increase the risk of constipation.
If concurrent use is essential, watch out for symptoms such as constipation, muscle cramps, injection site reactions, dizzine
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Erenumab Injection [Prescribing Information]. Thousand Oaks, CA: Amgen Inc.; 2018. [Accessed 12 May 2022] (online) Available from:
- Erenumab [Product Information]. Basel, Switzerland: Novartis Pharma AG; 2021. [Accessed 12 May 2022] (online) Available from:
- 3. Erenumab [EMC SmPC]. London, UK: Novartis Pharmaceuticals UK Ltd.; 2021. [Accessed 12 May 2022] (online) Available from:
- 4. Erenumab injection [Product Monograph]. Dorval, Quebec: Novartis Pharmaceuticals Canada Inc.; 2019. [Accessed 12 May 2022] (online) Available from:
- Erenumab [Patient Information Leaflet]. Basel, Switzerland: Novartis Pharma AG; 2022. [Accessed 22 Jun. 2023] (online) Available from:
- Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006. Erenumab. [Updated 2023 Apr 15]. [Accessed 22 Jun. 2023] (online) Available from:
Marketer details
Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
₹21438
Inclusive of all taxes
MRP₹24899 14% OFF
1.0 Solution for Injection in 1 vial
SOLD OUT
Notify me
